This CTD dossier owner and manufacturer specializes in oncology medications, with a focus on providing high-quality products that meet international pharmaceutical standards. They operate dedicated oncology units certified under both EU GMP and WHO GMP guidelines to ensure consistent quality across their range of products. Their key therapy areas likely revolve around cancer treatment, and they offer various dosage forms to address diverse patient needs. The company is committed to regulatory compliance, working closely with local and international bodies to maintain approvals for all their medications.

This CTD dossier owner and manufacturer specializes in oncology medications, with a focus on providing high-quality products that meet international pharmaceutical standards. They operate dedicated oncology units certified under both EU GMP and WHO GMP guidelines to ensure consistent quality across their range of products. Their key therapy areas likely revolve around cancer treatment, and they offer various dosage forms to address diverse patient needs. The company is committed to regulatory compliance, working closely with local and international bodies to maintain approvals for all their medications.

This pharmaceutical company specializes in oncology products, focusing on the treatment of both solid and hematological malignancies. They offer a range of chemotherapy medications, supportive care therapies, and injectable and oral dosage forms. Key therapy areas include various cancers affecting different organs and blood-related diseases. The company boasts a WHO GMP certified manufacturing facility in Hyderabad, India. Their production capabilities extend to 38 oncology APIs, allowing them to control costs while maintaining quality. They cater to both domestic and international markets. The company emphasizes innovation, employee empowerment, and a culture of equality and meritocracy.